DRREDDY's weekly performance was lackluster, with a return of -0.17% and a Sharpe Ratio of -0.15, indicating poor risk-adjusted returns. The stock's volatility was relatively low at 6.12%, but it still underperformed its peers, particularly DIVISLAB and SUNPHARMA, which posted returns of 3.43% and 3.45%, respectively. With a Max Drawdown of -0.5%, the stock was moderately risky this week.

[Volatility: 6.12%]